Aegerion Pharmaceuticals was acquired by Amryt Pharma plc 24 September 2019. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline. Please Follow us at https://www.linkedin.com/company/amryt-pharma-plc/
View Top Employees from Aegerion Pharmaceuticals| Website | https://www.amrytpharma.com/ |
| Employees | 46 (46 on RocketReach) |
| Founded | 2015 |
| Industry | Biotechnology Research |
| Web Rank | 7 Million |
| Keywords | Sol Barer, Novelion Investor Relations, Dr Mark Corrigan Synereca, Qlt Inc. Sedar, Aegerion Pharmaceuticals Inc. |
Looking for a particular Aegerion Pharmaceuticals employee's phone or email?
Aegerion Pharmaceuticals Questions
Tom Groeling is the Executive Director - Head of U.S. Marketing of Aegerion Pharmaceuticals.
46 people are employed at Aegerion Pharmaceuticals.
Top Aegerion Pharmaceuticals Employees
-
ViewPeter Ksenuk
Senior Clinical Project Manager at Aegerion Pharmaceuticals
Newton Highlands, Massachusetts, United States32 -
ViewTom Groeling
Executive Director - Head of U.S. Marketing at Aegerion Pharmaceuticals
Moorestown, NJ, US33 -
ViewJennifer Fitzpatrick
Vice President, Corporate Counsel at Aegerion Pharmaceuticals
Boston, Massachusetts, United States21 -
1
-
11
Related Companies
